comparative study to evaluate the effectiveness of ?igru tik?na pratis ?raniya K? ?ra against Ap ?m ?rga tik?na pratis ?raniya K? ?ra in the management of second degree Haemorrhoids.
Phase 2
- Conditions
- Health Condition 1: K641- Second degree hemorrhoids
- Registration Number
- CTRI/2024/07/070819
- Lead Sponsor
- VPSV Ayurveda college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants with second degree Haemorrhoids.
Age group of 21-60 years, irrespective of gender
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective assessment based on clinical signs and symptoms- Assessment of feeling of <br/ ><br>protrusion of mass during defecation Objective assessment based on Proctoscopy <br/ ><br>Photos of pile mass before and after the intervention will be included. <br/ ><br>Assessment of subjective and objective parametersTimepoint: As per the subjective and objective criteria,the assessment will be done on the day of kshara karma,and on 3rd day,5th day,7th day andfollowup will be done on 14 th day.
- Secondary Outcome Measures
Name Time Method Subjective assessment based on clinical signs and symptoms- Assessment of feeling of <br/ ><br>protrusion of mass during defecation Objective assessment based on Proctoscopy <br/ ><br>Photos of pile mass before and after the intervention will be included. <br/ ><br>Assessment of subjective and objective parametersTimepoint: before the study, 1st ,3rd, <br/ ><br>5th,7thday. <br/ ><br>Follow up will be done on 14th day <br/ ><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the therapeutic effects of ?igru tik?na pratis ?raniya K? ?ra in second degree hemorrhoids?
How does the efficacy of ?igru tik?na pratis ?raniya K? ?ra compare to standard-of-care treatments for K641 hemorrhoids?
Are there specific biomarkers that can predict patient response to Ap ?m ?rga tik?na pratis ?raniya K? ?ra in hemorrhoidal disease?
What are the potential adverse events associated with ?igru tik?na pratis ?raniya K? ?ra and how are they managed?
What related compounds or combination therapies are being explored for second degree hemorrhoids alongside these interventions?